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ABSTRACT  
Background:  Urinary tract infection (UTI) is common, often over-diagnosed, in long-term care 
(LTC) facilities and a source of inappropriate antibiotic prescription.  
Objectives: (1) Establish factors associated with a nurse’s decision to send a urine culture (UC), 
and if those factors were associated with a positive culture result; (2) to determine if 
antimicrobial therapy is associated with functional improvement.  
Method(s): 101 LTC residents were prospectively identified and assessed after submission of a 
urine specimen for culture. Logistic regression was performed to identify variables associated 
with a positive culture result. 
Result(s):  Change in behaviour, dysuria, and change in character of urine were the three main 
reasons for UC collection.  Male sex and change in mental status were the only significant 
predictors of culture positivity. Treatment did not lead to significant improvement in ADL score.   
Conclusion:  UCs obtained from LTC residents is often not appropriate and antibiotic treatment 
of residents from whom urine specimens are obtained does not lead to functional improvement.  
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Chapter 1: Introduction 
1.1 Urinary Tract Infection  
The urinary system can be categorized into an upper tract and a lower tract. The upper 
portion of the urinary tract includes the kidneys and the ureters, while the lower portion, 
contained in the pelvis, include the terminal parts of the ureters, the bladder and the 
proximal part of the urethra. UTI is a microbial infection occurring in any part of the 
urinary tract (1); lower tract infections include urethritis (i.e., inflammation or infection of 
the urethra), cystitis (i.e., bladder infection) and, in men, prostatitis (i.e., acute or chronic 
infection of the prostate gland)(2). Upper tract infection is commonly referred to as 
pyelonephritis or kidney infection (1, 2).  
UTIs can be further classified as uncomplicated or complicated (based on normal or 
abnormal underlying anatomy) and may be symptomatic but often they are not (2, 3). 
UTIs, while sounding simple, are hard to define (especially in elderly populations) and a 
concise definition of UTI and its associated symptoms does not exist; however, there are 
consensus guidelines that provide conserved criteria that are often used in diagnosis (4).  
The presence of bacteria in urine culture without symptoms is defined as asymptomatic 
bacteriuria (ASB).  
1.2 Risk Factors  
The elderly population (especially those in the long-term care [LTC] setting) are at an 
increased risk for developing many types of infections and will experience an increased 
morbidity associated with these infections (3). This predisposition to acquiring infections 
can be partly explained by age-related immune system changes, chronic disease(s), and 
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overall physical disability. In the LTC setting, additional factors such as closed 
environment (which favors a constant exposure to microorganisms) with frequent contact 
to personnel and other residents, and limited ventilation and filtration/removal of 
recirculated air (3) may also contribute.  
One of the most common infections in the elderly population (and the LTC 
population) are urinary tract infections (UTIs), accounting for 30-40% of all infections 
(5). The increased prevalence of UTI in the elderly can be attributed to age-related 
changes in the urinary tract including anatomic changes and/or altered physiology; but 
there are, however, other proposed risk factors including genetic and behavioural factors 
that increase the likelihood of acquiring UTI (3, 4). Additionally, comorbid conditions 
including diabetes, dementia and incontinence have all been described as independent risk 
factors for UTI (5).  
1.3 Clinical Presentation  
In the elderly, the symptoms associated with UTI are often highly variable and 
nonspecific (i.e., are not localized to the genitourinary tract)(4). Symptoms can be 
especially difficult to assess in those with diminished communication abilities and/or with 
poor baseline function (as is seen in the institutionalized elderly population)(4, 6). 
 Symptomatic infection, when it occurs, can present as acute lower-tract symptoms 
such as increased frequency (i.e., need to urinate more frequently), dysuria (i.e., burning 
upon urination), increased urgency, new onset or worsening incontinence or suprapubic 
discomfort (3, 7). Upper tract UTI presents with systemic symptoms such as fever and 
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costovertebral angle tenderness (i.e., back pain) or gross hematuria (i.e., blood in the 
urine) (3).  
Many physicians will believe that lethargy, confusion, change in mental status or an 
overall change in baseline function are associated with UTI, but these symptoms are not 
specific to UTI and can be difficult to assess in those with impaired cognition or chronic 
and/or extensive comorbidities (e.g., diabetes)(4). If such changes occur, other avenues 
such as recent medication changes should be evaluated before testing for UTI (8). 
Similarly, foul-smelling urine is often attributed to UTI but this may be due in part to 
other issues like dehydration (3, 9). A recent prospective observational cohort study found 
that the presence of malodorous urine and urine turbidity did not increase the likelihood 
of having a UTI nor did its absence decrease the likelihood of having a UTI – thus, these 
urine characteristics have no clinical utility in the evaluation of a potential UTI and 
should not be used as clinical indicators (10). Using smell and/or turbidity only increases 
the risk of patients being inappropriately treated with antimicrobials.   
1.4 Diagnosis  
Clinical diagnosis of UTI is difficult in the elderly population (3). Many elderly have 
chronic symptoms associated with comorbid disease and have difficulty in 
communication, which may interfere with clinical assessment (3, 11).  Furthermore, other 
chronic genitourinary symptoms like chronic incontinence are not associated with UTI, 
even though most individuals with these symptoms will have a positive urine culture (3). 
Twenty-five to fifty percent of institutionalized elderly have a positive urine culture at 
any given time, so residents with symptoms from any source will have a high probability 
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of a concurrent positive urine culture (3, 9). Only approximately 10% of episodes of fever 
without localizing symptoms in residents without an indwelling catheter will have a 
urinary source (3). 
When a physician suspects UTI, the minimum laboratory evaluation for UTI should 
include urinalysis (i.e., microscopic evaluation of the urine components) and urinary 
dipstick to evaluate for the presence of leukocyte esterase and nitrites (i.e., bacterial 
metabolites) (5). In fact, dipstick testing can be used effectively to rule out UTI if it is 
negative for leukocytes esterase and nitrites since it has been shown that the negative 
predictive value for such components is close to 100% (12).  
Other laboratory investigations for evaluation of  UTI may include a urine culture. 
Urine culture is a diagnostic test in which collected urine is incubated on culture media 
and bacteria are identified. Urine culture will determine how many bacteria are present in 
the sample; this should be collected prior to initiation of antimicrobial therapy. If bacteria 
are present (i.e., the urine culture is positive representing significant growth), this 
signifies bacteriuria (i.e., bacteria in the urine) and can be quantitatively represented by 
reporting the number of bacteria colony-forming units per litre (CFUs/L). The threshold 
for reporting a urine culture as positive may vary, but is often reported as 106 CFUs/L, 
according to the Clinic and Laboratory Standards Institutes published guidelines. If no 
bacteria are present or there are not enough bacteria present, the culture will be reported 
as negative, signifying non-significant growth.  
A positive urine culture is not sufficient to diagnose a UTI but it is required for the 
microbiologic diagnosis (3). That is, a positive urine culture will provide the 
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identification of the bacteria (or yeast) as well as provide antimicrobial susceptibility to 
aid in treatment decisions. A negative urine culture, however, will exclude the possibility 
of a urinary tract infection (3). 
Unfortunately, however, there are significant problems that are frequently 
encountered in the collection, testing and interpretation of urine samples (4). Ideally, a 
urine specimen should be collected with mid-stream urine via the clean-catch method. If 
this not possible, such as in cases where controlled voiding is impossible or in highly 
functionally impaired patients, an in-and-out catheterization should be performed to 
collect the sample. This methodology is to minimize bacterial contamination of the 
specimen by normal genitourinary flora (especially in females) that will increase the 
likelihood of having a false-positive culture or lead to misinterpretation of normal flora as 
pathogenic (leading to inappropriate antimicrobial treatment) (3, 4). Furthermore, in those 
residents with a chronic indwelling catheter, the existing catheter should be removed and 
a new catheter inserted prior to obtaining the urine sample. Bacterial biofilms form on the 
interior surface of the catheter and as a result, culture collected in this way do not 
represent the actual bladder microbiology (4). Unfortunately, adherence to ideal 
collection methods may be inadequate as shown by Pallin et al. (2014) in the acute-care 
setting (which is not often different than the LTC setting) (4, 13).  
1.5 The Issue of Over-Diagnosis  
 The most common bacterial infection diagnosed among residents in LTC setting is 
UTI (11).  While diagnosis of UTI is common in LTC, it is often incorrectly diagnosed 
(14).  LTC residents have a high prevalence of asymptomatic bacteriuria (ASB) which 
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contributes to over-diagnosis of UTI (15).  Physicians must decide if a resident’s clinical 
decline is due to UTI or some other etiology.  UTI can present with a continuum of signs 
and symptoms from localized genitourinary (GU) symptoms such as dysuria, to 
bacteremia, resulting in septic shock (11).  The elderly, however, may present with 
atypical or non-localizing symptoms which are hard to discern because many residents in 
LTC have severe chronic comorbidities such as diabetes and heart failure or may have 
chronic GU symptoms from additional comorbid illnesses which clouds the identification 
of new or worsening symptoms (5, 11).   
While published diagnostic guidelines for UTI in LTC exist, they have never been 
clinically validated (16) nor updated since their publication in the early 1990s (17). There 
is low adherence to these guidelines among physicians, since guidelines require that 
treatment be limited to residents with localized GU symptoms (18).  As a result, when a 
resident is showing signs of clinical alteration or decline, a common practice is to send a 
urine specimen for culture .  Urine culture, when positive, may not be useful in 
establishing a diagnosis of UTI given the high prevalence of ASB in this population (14).   
Many of the signs and symptoms identified by nurses, physicians, or family as 
UTI are not attributable to UTI at all (19).  Practitioners surveyed have suggested that 
factors such as a change in the character of urine (colour, turbidity, and odour), change in 
mental status or increased falls are associated in the LTC setting with UTI (20), but 
evidence does not support this (21, 22).  Generalized non-specific symptoms may be 
caused by concurrent illnesses.  For example, a change in the character of urine can be 
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caused by dehydration or diet (9, 19) and a change in mental status can be caused by other 
infections, dehydration or an adverse effect from new medication (9).  
1.6 Asymptomatic Bacteriuria (ASB) 
Confounding the usefulness of urine culture in LTC is the high prevalence of 
ASB.  Twenty-five to fifty percent of women and 15-40% of men in LTC without an 
indwelling catheter have ASB (11). ASB is associated with increased functional 
impairments, bladder and bowel incontinence, and cognitive impairment (9).  The main 
contributing factor to the prevalence of ASB is likely voiding abnormalities that are often 
associated with neurological disease such as cerebrovascular disease, Parkinson’s and 
Alzheimer’s disease (11), of which many LTC residents are afflicted. 
ASB is defined as the presence of bacteria or yeast in the urine (>106 colony-
forming units/litre) in the absence of any urinary specific symptoms (6, 19). Prevalence of 
ASB is highest in LTC residents with severe functional impairment, and treatment of 
ASB is not associated with a decrease in rate of symptomatic infection or survival (5, 9, 
15, 23, 24).  Despite this, ASB accounts for one-third of prescriptions for suspected UTI, 
with one study finding that half of antibiotics prescribed for suspected UTI were 
administered to ASB patients (25, 26).   
There is no evidence that treatment for ASB is beneficial, since treatment does not 
reduce the prevalence of bacteriuria, frequency of symptomatic UTI or mortality (14, 25).  
In fact, re-infection or development of symptomatic UTI is more likely to occur early 
post-treatment (11). Treatment of ASB may be harmful, as it can lead to the emergence of 
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multi-drug resistant organisms (MDROs), increase adverse drug events and increase rates 
of Clostridium difficile associated diarrhea (CDAD) (19, 25, 27).  In a study of  nursing 
homes in Rhode Island, residents with ASB treated with antibiotics were 8.5 times more 
likely to develop CDAD within three months following treatment (28).  
1.7 Difficulty with Ascertaining Signs and Symptoms  
Residents with cognitive impairment or decline are more likely to have a positive 
urine culture than residents without cognitive impairment (15).  Residents with baseline 
cognitive dysfunction frequently experience further cognitive deterioration with any 
change in status (19).  Therefore, a LTC resident identified as having changes in mental 
status will often have bacteriuria (positive urine culture), which leads to inappropriate 
antibiotics being prescribed in residents with ASB (19).  If the resident’s condition 
improves, irrespective of whether this is attributed to the antibiotic therapy, physicians 
and nurses may be more likely to initiate antibiotic treatment in the future for such non-
localized symptoms (9), especially in the absence of validated diagnostic criteria.  
When a resident presents with diffuse, non-specific symptoms such as 
restlessness, fatigue, or not “being themselves” (21) it is hard to distinguish between UTI 
and ASB.  Physicians often manage LTC patients by telephone using nurse’s reports of 
clinical findings, rather than examining the resident (9), and nurses often order urine 
cultures based on their own assessment (29).  As a result, when a positive urine culture is 
received an antibiotic may be inappropriately prescribed due to inadequate 
communication between physicians and nurses. (29).  Similarly, with receipt of a positive 
urine culture, a physician when deciding to prescribe antibiotics, must assess the short-
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term (i.e., failure to treat an emerging infection) and long term risks (i.e., contributing to 
antimicrobial resistant organisms); typically in this situation, the short term risks are 
perceived to outweigh the long-term risks (25).  These factors may contribute to over-
diagnosis and overtreatment of UTI.    
1.8 Solutions to curb the issue of over-prescribing and over-diagnosis  
Usually, LTC settings may not have the benefit of a local antimicrobial 
stewardship program (ASP) as hospitals have.  ASP is the practice of using the correct 
antibiotic, at the optimal dose, duration and frequency to cure an infection, while 
minimizing risks to the patient and limiting the development of antimicrobial resistance 
(9).  Currently, there is no standardization of stewardship components, implementation 
strategies or evaluation for LTC (30), but ideally a stewardship intervention would focus 
on standardizing indications for initiation of treatment for UTIs, limiting the chronic or 
prophylactic use of antimicrobials, and promoting short-course therapy for bacterial 
infections (31).  Implementation of an ASP can reduce drug costs, antimicrobial 
resistance and rates of nosocomial infections (31, 32).   
Multifaceted interventions like clinical algorithms targeting nurses and physicians 
have been shown to reduce the rate of antibiotic prescription for urinary indications (39% 
prior to intervention versus 28% following intervention, weighted mean difference -9.6%, 
-16.9% to -2.4%)(26).  Interventions such as the one employed by Standford Place Care 
Campus on Vancouver Island, Canada included a self-learning package on ASB and UTIs 
combined with a clinical pathway for diagnosis and management of UTIs; they found an 
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improvement in communication between nurses and physicians, improved clinical 
diagnosis and a 36% reduction in antibiotic-treated UTIs (29).   
Before an ASP can be implemented, it is pertinent to know the local habits with 
regards to diagnosis and treatment of UTIs in LTC facilities.  We performed a 
prospective, observational study to determine the reason(s) that nurses in LTC were 
ordering urine cultures, and if these reasons for collection were associated with a positive 
urine culture. Similarly, we wanted to examine if physicians were making decisions 
consistent with published guidelines [McGeer criteria(17)] for diagnosis of UTI in 
residents without an indwelling catheter. At the time of the study, physicians and staff 
were not following any type of local guideline. We also assessed the clinical response of a 
resident to therapy by measuring their functionality prior to treatment, during treatment 
and following treatment.  To date, no other study has examined clinical outcomes 
following therapy for UTI in LTC.  
1.9 Thesis Objectives  
The primary objectives of this study were: 
1. Identify the reasons associated with a nurse’s decision to send a urine sample for 
culture 
2. Identify the symptoms associated with positive urine culture 
3. Assess clinical response to antibiotic therapy by measuring the patient’s 
functional ability and initial symptoms and continuing to monitor their status by 
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reassessing the patient at 48-hours and 5-7 days following treatment initiation for 
all included patients.   
The secondary objectives(s) were: 
1. To determine if a physician’s decision to treat the suspected UTI with 
antibiotics complied with the culture and sensitivity reports released by the 
microbiology laboratory 
2. To determine if treatment decisions followed published guidelines (17) for 
diagnosis of UTI in patients without an indwelling catheter. 
 
The role of Carla Penney in this study was data collection and performing data analysis. 
(ethics, manuscript publication, study design). 
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Chapter 2: Methods 
2.1 Study Design  
 The study was a prospective, observational cohort examining the behaviour of 
LTC nursing staff who submitted a urine culture specimen from a resident specimen. The 
nurse (or delegate) who collected the specimen was identified and interviewed at several 
time points, including the day the urine specimen was submitted to the microbiology 
laboratory for culture, and 48-hours and five to seven days following urine culture 
submission.  Therefore, the study prospectively enrolled specimens but retrospectively 
examined the behaviours of nurses.  The study was approved by Health Research Ethics 
Authority, who granted permission for research staff to approach nursing staff to collect 
relevant data.  Information sheets on the study and consent forms were circulated to all 
participating LTC facilities prior to initiation of the study.  A sample size calculation was 
not performed but determined based on feasibility; a sample size of 100 specimens was 
chosen.  
2.2 Setting and Participants  
 Six LTC facilities (LTCF) (Agnes Pratt, Glenbrook Lodge, former Hoyles-
Escasoni, St. Patrick’s Mercy, Saint Luke’s and Masonic Park) located in the metro-
region of St. John’s, Newfoundland, were selected for inclusion in the study based on 
their high urine culture submission rates.  These facilities range from 40 to 377 patient 
beds with most facilities providing level three and level four care to residents (i.e., those 
who require moderate to total assistance with daily functioning).  
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 Participants were identified based on receipt of a urine specimen from one of the 
participating LTCF by using the search function in the MEDTECH EHR system.  
Following identification, a researcher (CP) visited the relevant LTCF to determine further 
patient eligibility by interviewing the nurse (or delegate if the nurse was unavailable) who 
collected and submitted the urine.  Receipt of a urine in the microbiology laboratory was 
considered sufficient evidence that the submitting nurse suspected a UTI.  
 Participants were not included in the study if they were not anticipated to remain 
in the LTCF (e.g., short-term resident or pending discharge); had an anticipated life 
expectancy of less than four weeks as assessed by nursing staff; were less than 65 years of 
age; had an indwelling catheter or other surgical urinary collection device; were currently 
on renal dialysis; were receiving antimicrobials for any indication or if they had resided in 
the LTCF for less than four weeks (staff are unable to determine resident’s baseline 
functional status).  
2.3 Data Collection  
 Between June 24 and July 17, 2013 and between January 20 and March 20, 2014, 
consecutive urine samples received in the clinical microbiology laboratory from the 
LTCF were identified.  Once at the LTCF, the researcher identified the nurse who 
collected the urine to request the reason(s) for the urine submission.  The nurse (or 
delegate) was interviewed at three time points to collect patient information including 
comorbidities, baseline functional capacity (28-point score of activities of daily living 
(long- form ADL) scale (RAI-MDS 2.0)(33) including mobility in bed, transfers, 
locomotion, dressing, toileting, personal hygiene and feeding, and a four-point mental 
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status care).  This scale was completed at the time of the initial interview by the 
researcher asking the nurse (or delegate) which activities required assistance by the 
resident at that time and to what degree, with the researcher tallying the final score; the 
same procedure was followed for determining the resident’s current mental status.  The 
patient, the patient’s caregivers, the patient’s family and the attending physician were not 
interviewed.  
2.4 Main Study Outcome  
Urine culture was performed quantitatively, according to laboratory protocol and 
reported according to CSLI guidelines (34). A positive urine culture result was defined as 
a growth of at least 106 colony-forming units/liter of uropathogenic bacteria. 
2.4.1 Baseline Variables Assessed 
Study variable(s) considered to be possibly associated with significant growth in 
urine culture were selected based on previous literature. This included: resident’s 
demographic characteristics (age, gender, LTC facility, total comorbidities); reasons for 
collection (change in mental status, change in behaviour, change in character of urine, 
fever, change in gait or fall, change in voiding pattern, flank pain, patient or family 
request, abnormal laboratory test result, dysuria, change in functional status, previous 
UTI, malaise); baseline functional capabilities (ADL score [scored out of 28], 
disorganized speech, altered perceptions, unresponsive episodes or lethargy in the past 
seven days), and nurse-reported symptoms which were listed as dichotomous variables 
(i.e., yes or no); these variables included fever, change in behaviour, change in mental 
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status, diarrhea, abdominal pain, shortness of breath, weakness, dysuria, change in 
character of urine, change in frequency of urination, and flank pain.  Values with two or 
fewer positive responses were eliminated (change in functional status, change in gait or 
fall, result of other workup performed, other concurrent infection, dehydration, shortness 
of breath, syncope, diarrhea, baseline unresponsiveness, cough). 
2.5 Data Analysis 
 Analyses were performed using SPSS Version 20.0 (IBM Corporation, USA).  
First, percentage of baseline characteristics were presented for categorical variables, and 
mean and standard deviation (SD) for continuous variables. Univariate logistic regression 
was first performed to determine if nurse-reported symptoms were associated with the 
main study outcomes. Change in functional status (ADL score) over time was analyzed 
using a repeated measures ANOVA comparing the three time-points (baseline, 48 hours 
and 5 to 7 days).  Symptoms and functional status were qualitatively described over time.   
 A multivariable logistic regression was performed following results of the 
univariate regression.  The factors identified from the univariate regression with a p-value 
less than and equal to 0.2 were included in the multiple regression to determine their 
association with significant growth.  These variable(s) included: male sex, long-term care 
facility, change in voiding pattern, patient or family request, change in mental status, and 
change in character of urine. 
  
 
 
 
24 
 
 
Chapter 3: Results  
3.1 Participant Flow  
 Participants were recruited as outlined in Figure 1.  In total, 174 specimens were 
screened for inclusion, with 73 specimens excluded.  One-hundred and one (101) 
specimens from 101 participants were included for data analysis; 63 specimens had urine 
culture result of non-significant growth (including those cultures with mixed-growth 
contamination) and 38 specimens had urine culture result of significant growth.  The 
recruitment was stopped when the sample size was reached. 
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Figure 3.1: Participant Flow  
 
3.2 Participant Demographics  
 The patient demographics are summarized in Table 3.1.  The study population was 
79.2% female, had a mean (±S.D.) age of 84.0 ± 8.6 years and had an average of 1.8 ± 1.0 
comorbidities per patient, with the most common being dementia (57.4%).  The baseline 
ADL score was 11.9 ± 8.7 (where a score of zero representing total independence and a 
174 specimens screened for 
inclusion  
73 specimens excluded:  
- 2  Discharge pending  
- 11  <65-years old  
- 21  Indwelling catheter  
- 12  Recent admission  
- 1  Dialysis  
- 8  Chronic antibiotics  
- 17  Recent antibiotics  
101 episodes in 101 patients     
38 Significant 
Growth   
63 Non-significant 
Growth    
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score of 28 representing total dependence).  Nineteen (18.8%) patients experienced 
altered perception or lethargy, 12 (11.9%) patients experienced disorganized speech and 1 
(1.0%) patient experienced unresponsiveness in the seven days prior to urine collection.   
Table 3.1: Demographic characteristics  
Characteristic (n=101) Value 
  Age, years, mean ± SD 84.0 ± 8.6 
  Female sex, % 79.2 
  Long-term Care Facility, n (%)   
      A, n (%) 26 (25.7) 
      B, n (%) 9 (8.9) 
      C, n (%)  23 (22.8) 
      D, n (%)  20 (19.8) 
      E, n (%)  15 (14.9) 
      F, n (%)  8 (7.9)  
  Number of comorbidities, mean ± SD 1.8 ± 1.0 
      Dementia, n (%) 58 (57.4) 
      Stroke, n (%) 13 (12.9) 
      Liver disease, n (%) 1 (1.0) 
      Depression, n (%) 41 (40.6) 
      Kidney disease n (%) 12 (11.9) 
      Diabetes, n (%) 25 (24.8) 
     Cancer, n (%) 9 (8.9) 
     COPD, n (%) 15 (14.9) 
  Baseline ADL Score, mean ± SD 
(Independent = 0, Total Dependence = 28) 
11.9 ± 8.7 
  Mental status in past 7 days, n (%) 
 
  Disorganized speech  12 (11.9) 
  Altered Perception 19 (18.8) 
  Unresponsiveness 1 (1.0) 
  Lethargy 19 (18.8) 
 
3.3 Primary Outcome  
 Table 3.2 outlines the reasons that nurses collected urine for culture, and Table 3.3 
outlines the factors correlated with significant growth (i.e., positive urine culture).  
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Reasons for urine collection ranged from one to seven reasons (mean 2.0 reasons).  
Change in behaviour (34.7%), dysuria (30.7%) and change in character of urine (29.7%) 
were among the most common reasons for submission.  Change in mental status (25.7%) 
and change in voiding pattern (20.8%) were also common reasons for submission.  
Male sex (OR = 5.58, [95% C.I. = 1.23, 25.43]) and change in mental status (OR 
= 13.83, [95% C.I. 1.8, 105.81]) were the only statistically significantly associated 
variables with positive urine culture in binomial regression analysis.  LTCF (OR = 1.39, 
[95% C.I. 0.95, 2.02]), change in character of urine (OR = 14.51, [95% C.I. = 0.66, 
320.71]) and baseline periods of lethargy (OR= 4.20, [95% C.I. = 0.91, 19.37]) 
approached significance.   
A final multiple logistic regression was performed using predictors identified from 
the univariate logistic analysis with a p-value = 0.2; the factors included in the model 
were gender (male sex), LTCF, change in voiding pattern, patient or family request, 
change in mental status and change in character of urine. Table 3.4 illustrates these 
results.  The model was not statistically significant (χ2(39) = 39.16, p-value = 0.463) and 
only explained 10.3% of the variance in factors associated with significant growth. While 
not significant, LTCF, and family request for urine culture, were 1.9 (OR = 1.86, [95% 
C.I. = 0.341, 10.226]) and 2.4 (OR = 2.37, [95% C.I. = 0.456, 12.40]) times more likely 
to have a significant growth culture result, respectively.  
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Table 3.2: Reasons for urine culture collection (n = 101)  
Clinical Reason n % (N=101) 
Change in behaviour 35 34.7 
Dysuria 31 30.7 
Change in character of urine  30 29.7 
Change in mental status  26  25.7 
Change in voiding pattern  21 20.8 
Other reason  14 13.9 
Patient or family request 11 10.9 
Previous UTI 11 10.9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
29 
 
Table 3.3: Binary logistic regression of predictors with significant growth (n = 38 of 
101 episodes)  
Demographics OR 95% C.I. p-Value  
Age 0.99 0.93-1.06 0.79 
Male Sex 5.58 1.23-25.43 0.026 
Total Comorbidities 0.87 0.53-1.47 0.61 
LTC Facility 1.39 0.95-2.02 0.087 
Stated Reason for Urine Collection     
Fever 0.00  1.0 
Change in voiding pattern 16.70 0.16-1754.36 0.24 
Patient or family request 0.12 0.007-1.91 0.13 
Abnormal laboratory test result 2.85 0.16-51.27 0.48 
Previous UTI 1.28 0.19-8.48 0.80 
Baseline Functional Capacity    
Baseline ADL Score 1.03 0.97-1.10 0.38 
Baseline Disorganized Speech 1.02 0.14-7.59 0.97 
Baseline Altered Perception 0.36 0.05-2.60 0.31 
Baseline Periods of Lethargy 4.20 0.91-19.37 0.065 
New Symptoms    
Change in Behaviour 3.41 0.11-104.90 0.48 
Change in Mental Status 13.83 1.81-105.81 0.011 
Abdominal Pain 0.68 0.083-5.60 0.72 
Weakness  0.90 0.026-30.91 0.95 
Worsening in ADL Score 0.00  1.0 
Dysuria 2.10 0.14-32.13 0.60 
Change in Character of Urine 14.51 0.66-320.71 0.090 
Flank Pain infinity  1.0 
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Change in Frequency of Urination 0.079 0.002-2.62 0.16 
 
Table 3.4: Multiple logistic regression model of predictors with significant growth 
culture results  
Variable Odds Ratio 95% C.I. p-value 
Male Sex  0.48 0.16, 1.45 0.19 
Long-term care 
facility 
1.87 0.34, 10.23 0.47 
Change in voiding 
pattern 
1.07 0.37, 3.12 0.90 
Patient or family 
request 
2.38 0.46, 12.40 0.30 
Change in mental 
status 
1.09 0.38, 3.15 0.87 
Change in character 
of urine 
1.07 0.41, 2.80 0.89 
 
A repeated measures ANOVA with a Greenhouse-Geisser correction determined 
that mean ADL score was not statistically significantly different between time points 
(F(1.070, 102.714) = 0.891, P = 0.350).  The primary outcome of clinical response to 
therapy is presented in Table 3.5.  Using a two-sided paired t-test, the patient’s ADL 
score at baseline (prior to clinical decline which prompted the urine collection) was 
compared to their ADL score at 48-hours (the time at which culture results are available 
to the physician), and their ADL score at five to seven days (when resolution of episode 
should occur), in groups based on their culture result and treatment decision.  There was 
no significant difference observed in functionality in any combination of groups (i.e., 
baseline to 48-hours or between 48-hours and 5-7 days).  
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Table 3.5: Changes in activities of daily living (ADL) score* 
Group N Mean 
ADL 
Baseline 
Mean 
ADL 48 
Hours 
p value 
Baseline to 48 
Hours 
Mean 
ADL 5-7 
days 
p value 48 
Hours to 5-7 
Days 
Culture positive, 
treated 
28 11.5 12.2 0.30 12.2 1.00 
Culture positive, 
not treated 
9 17.6 16.4 0.35 16.4 1.00 
Culture negative, 
treated 
18 12.1 12.1 1.00 12.1 1.00 
Culture negative, 
not treated 
44 10.9 11.2 0.29 11.3 0.34 
  * Zero represents total independence, 28 represents total dependence  
3.4 Secondary Outcomes  
 The secondary outcome of the physician’s decision to treat given culture results is 
presented in Table 3.6.  Antibiotics were prescribed in 48 of 101 episodes (47.5%); of 
those treated, 25 (24.8%) were prescribed nitrofurantoin and 14 (13.9%) were prescribed 
TMP/SMX.  Agreement between treatment decision and significant growth was fair (κ = 
0.44) but antibiotics were incorrectly prescribed to patients with nonsignificant growth in 
19/48 (40%) of prescriptions.  Nine (17.0%) of 53 patients who had a culture result of 
significant growth were not prescribed antibiotics.  Of the 101 specimens included, 32 
(31.2%) were considered inappropriate (Table 3.6) using urine culture result as the 
reference standard; it should be noted that the culture result alone does not distinguish 
between UTI and ASB.  Treatment duration lasted for a mean of 7.6 ± 2.5 days with a 
range of 1 day to 15 days.  The time between urine submission and start of treatment was 
an average of 1.44 ± 2.9 days with a range of treatment given eight days prior to 
collection for the presumed UTI and ten days following collection for the same.  
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Of the 38 urine specimens collected with significant growth, 25 (65.8%) grew 
Escherichia coli, five (13.2%) grew Proteus species, four (10.5%) grew Klebsiella 
species, three (7.9%) grew Enterococcus species and one (2.6%) grew yeast.  
Table 3.6: Treatment decision  
 Treatment Decision   
Growth Antibiotic Prescribed Antibiotic Not 
Prescribed  
Total 
Significant Growth 29 (60) 9 (17)* 38 
Non-significant 
Growth 
19 (40)*  44 (83) 63 
Total 48 53 101 
  * Inappropriate treatment decision.  Data presented as n or n (%)   
A binary logistic regression showed that a resident’s age, gender, LTC facility, 
number of total comorbidities and baseline ADL were not associated with the decision to 
treat (Table 3.7) .  In 21 (43.8%) of 48 treated cases, treatment was given before 
preliminary culture results were available.  Among those patients with a positive culture 
who were treated, four (13.7%) of the 29 patients were given an antibiotic to which the 
isolated bacteria were reported as resistant.  
Table 3.7 Binary logistic regression of predictors of treatment decision  
Variable Odds Ratio 95% C.I.  p-value  
Age 0.974 0.927, 1.023 0.295 
Male Sex  0.626 0.230, 1.704 0.626 
Total Comorbidities  0.725 0.725, 0.480 0.725 
Baseline ADL  0.992 0.947, 1.040 0.992 
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 The secondary outcome of whether the physician was following published 
guidelines for diagnosing UTI in the long-term care population without an indwelling 
catheter was examined.  These guidelines may include vital signs and blood counts, but 
most observed episodes did not have a record of vital signs or blood testing so it was 
concluded that physicians and/or nursing staff were not following guidelines.  Body 
temperature was measured for eight (7.9%) episodes, blood pressure was measured for six 
(5.9%) episodes, a dipstick was performed for 25 (24.8%) episodes and a complete blood 
count was obtained for 16 (15.8%) episodes.  
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Chapter 4: Discussion 
4.1 Findings and Implications  
 This study found that most of the reasons why nurses chose to collect a specimen 
were not associated with a positive culture result.  Male sex and change in mental status 
were the only two significant predictors of significant growth (i.e., positive urine culture) 
in our binary logistic regression analysis.  
The finding that gender contributed to the predictive value of urine culture may 
have been attributed to males providing a cleaner urine collection than females (females 
were twice as likely to have a culture result of “mixed growth contamination” than males 
– 15 (18.8%) versus 2 (9.5%), respectively).  A change in baseline mental status was a 
predictor of significant growth in the binary logistic regression. This loss significance in 
the multivariate logistic regression.  Twenty-two (57.9%) residents with a positive urine 
culture result were reported to have dementia, compared to 37 (58.7%) without a positive 
urine culture result, suggesting that dementia alone may explain the association between 
the change in mental status and positive urine culture.  Residents with cognitive 
impairment or decline are more likely to have a positive urine culture (19).  Our data 
cannot provide the specific etiology for a change in mental status, so the correlation 
between change in mental status and positive urine culture may be due to another 
confounding fact.   
 Our study also found that culture results did not appear to influence a physician’s 
decision to treat a suspected UTI, since physicians chose to treat residents with culture-
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negative results (40% of recorded episodes) and chose not to treat those with culture-
positive results (17% of recorded episodes).  Physicians also treated residents prior to 
culture results becoming available, and sometimes  prescribed antibiotics to which the 
organisms were resistant.  This observation may be explained by several factors.  Nurses 
in the LTC setting have a major influence on whether a physician prescribes an antibiotic.  
They often are more familiar with residents and would notice subtler changes in their 
clinical status than a physician and often advocate treatment on their behalf.  
Furthermore, individual prescribing behaviour of physicians may play an important role.  
For example, an on-call physician not familiar with a LTC facility may prescribe an 
antibiotic without performing an assessment, to act conservatively to prevent further 
complications.  Pressure from family members is a factor to consider as well. Often a 
family member will feel that something is “off” about their loved one and request a urine 
culture to be submitted and subsequently, request an antibiotic (27).    
Prescribing behaviour in response to positive (or negative) culture results could be 
addressed through education of both physicians and nurses including development of 
treatment algorithms and continuing audit and feedback (35), but this is resource 
intensive and behaviour changes are rarely sustained.  Other forms of intervention like 
changes in urine culture reporting can have a significant influence on prescribing 
behaviour; a recent study performed in the acute care setting saw an absolute risk 
reduction of 36% (C.I. = 15%-57%, p = 0.002) for treatment of ASB among non-
catheterized inpatients (36) by simply restricting reporting of urine culture results, and 
requesting the physician to call the laboratory to release sensitivity results. But if 
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physicians chose to treat without obtaining culture results, then this intervention would 
not be effective.  
 Similarly, the current study attempted to evaluate whether physicians were 
following published clinical guidelines.  The intention was to capture whether criteria 
were being followed at the time of the nurse (or delegate) interview (refer to Appendix 3).  
Many of the LTC facilities only recorded vital signs on a quarterly basis, and in some 
instances, less frequently, as some residents are difficult and uncooperative.  Vital signs 
were accessed through the LTC EHR system, and therefore any vital signs not accessible 
to our analysis.  Because vital signs were not collected or available, we could not evaluate 
adherence to treatment guidelines which require changes in vital signs for UTI diagnosis.   
Many providers may be unaware of current published guidelines (37), and these 
guidelines may not address residents who present with only non-localizing symptoms (5).  
Likewise, these guidelines are difficult to apply to residents with advanced dementia who 
are non-verbal and cannot reliably express any symptoms they may be experiencing (38). 
For example, over half (57.4%) of the residents assessed in the present study were listed 
as having dementia, so it is reasonable to assume that they represent a large proportion of 
LTCF populations for which the minimum criteria guidelines would be hard to apply.  
There is also evidence to suggest that even if prescribers adhered to the published 
guidelines, that it would not be associated with lower rates of antibiotic prescribing but 
rather a higher rate of inappropriate antibiotic prescribing (39).  Thus, it seems that there 
is a need for updated, evidence-based guidelines.  
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 In the present study, we also aimed to assess the clinical response to antimicrobial 
therapy by measuring change in functionality using the ADL score.  We observed no 
functional improvement associated with antibiotic treatment (Table 5).  ADL scores did 
not change significantly during the seven-day follow-up period, even when stratified by 
treatment and culture result; this suggests that antibiotic therapy did not have clinical 
benefit.  This calculation, however, is based on mean change in ADL; it is possible that 
individuals did benefit with treatment over the study period but not so that it was 
detectable.  Of the residents assessed, only 7 out of 101 (6.9%) demonstrated individual 
improvement and/or decline in ADL over the study period.  Response bias may have 
influenced in the lack of ADL improvement observed, because if the same nurse (or 
delegate) completed the scale each time, they may have given the same answer without 
much reflection.  Which nurses were interviewed during the study period was not 
recorded, therefore this bias cannot be excluded.   
The study population at baseline had moderate functional impairment (ADL Score 
11.9 ± 8.7) which may explain why we did not see any improvement with therapy 
compared to a population with mild or no functional impairment. For example, if a 
resident who previously was able to ambulate but experienced a functional change 
whereby they couldn’t ambulate well anymore – treatment would appear to benefit them 
more so than a resident who is always non-ambulatory. Additionally, the follow-up period 
may not have been long enough to detect a further functional decline.  Without a 
randomized design, culture-positive and culture-negative residents may have differed at 
baseline leading to a biased observation.   
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 We observed a culture positivity rate  among those residents with urine collected 
to be similar to that of the published rate of ASB for the LTC population (38% versus 
40%, respectively)(5, 15).  This is consistent with previous studies (40) suggesting that 
clinical suspicion of UTI is not contributory without further investigation of any signs and 
symptoms.  
Published clinical criteria for UTI do not have high accuracy.  When compared 
against laboratory evidence of UTI, the positive-predictive value of the published 
diagnostic criteria ranged from 52%-57% (6, 16).   It may be more useful to consider 
using a urine dipstick test to exclude the possibility of UTI, as a negative dipstick for 
leukocyte esterase and nitrite has been known to have a 100% negative-predictive value 
(12).  
4.2 Limitations  
 Our study had several limitations, with the main limitation being a small sample 
size.  A sample size calculation was not performed; thus, we may have been 
underpowered to detect a significant predictor.  Typically, a guide of ten events per 
predictor tested would be needed to achieve a sufficient sample size; in this study, an 
event would be a positive culture meaning that we would require a minimum of 100 
positive urine culture results.  The inadequate sample size is reflected in our wide 
confidence intervals.  
The second limitation was that we only considered input from LTCF nurses (or 
delegates).  Physicians, other caregivers or family were not consulted or interviewed 
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regarding the signs and symptoms of UTI, and they may have had differing perceptions.  
Nurses, however, in the LTC setting are very influential with regards to a resident’s care; 
they would relay any clinical change to the physician. In many instances, we were not 
able to interview the nurse who collected the urine specimen due to changes in shifts; the 
nurse on the next shift may not have yet known the reasons for urine collection.  Finally, 
measuring ADL score as a response to therapy may not have captured other significant 
evidence of clinical improvement.  The reliability of this scale over short intervals of time 
is not known and this may have contributed to our lack of functional improvement seen; 
typically, ADL is assessed every 90 days in LTC.   A different scale measuring health 
outcomes may have been useful in this study as physicians may be more inclined to treat 
residents who are experiencing a decline in their perceived quality of life due to any signs 
and symptoms of UTI they may be experiencing; this could explain why some residents 
received treatment even though they were culture negative.   
4.3 Future Studies  
 The present study was the first to observe clinical outcomes (ADL score) as a 
measure of effectiveness of diagnosis and treatment for UTI in the LTCF setting.  Future 
studies should evaluate diagnostic criteria for UTI based on clinical benefit following 
successful treatment instead of based on culture.  Additionally, future studies should 
explore methods to reliably separate ASB from UTI among LTC residents with severe 
cognitive impairment.  Kjölvmark et al. produced a study reporting moderate accuracy 
using specific urinary biomarkers (41).  This type of diagnostic test would be useful in 
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further studies to see which biomarkers predict improvement in clinical status in response 
to treatment of bacteriuria.   
There is also adequate equipoise to suggest a prospective, randomized clinical trial 
comparing early to delayed antibiotic treatment, or comparing antibiotic treatment with 
rehydration (19).   
Lastly, a final suggestion for future studies would be to implement a delirium 
protocol for diagnosis of UTI in LTC and preform a pre- and post-intervention analysis.  
This type of protocol is used in both acute and intensive care settings.  In this protocol, 
functional decline or other decompensation experienced by LTC residents would be 
investigated in a flow-chart type manner to ultimately reduce the number of urine cultures 
performed and the number of antibiotics prescribed.  For the febrile resident without 
localizing symptoms, blood cultures would be collected since a diagnosis of UTI can be 
made if a blood culture isolate is the same as the organism isolated from the urine, given 
there is no alternative site of infection (9).  In the afebrile resident, hydration would be 
encouraged to rule out dehydration as a source of clinical decline.  If deterioration 
persists, further investigation would be warranted including a physical exam and blood 
count.  If a resident has localizing urinary symptoms, a urine culture may be collected 
using an in/out catheter and a urine dipstick test should be performed.  Treatment for UTI 
would be considered only for those with a positive dipstick result for leukocyte esterase 
and a positive urine culture.  Finally, this protocol, when evaluated, could be audited to 
ensure compliance and impact on antibiotic prescription rate.    
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Chapter 5: Conclusions  
While not adequately powered to determine a significant association, our study is 
able to conclude that diagnosis of UTI in LTCF is still not well defined and that the 
perceived symptoms of UTI are not predictive of significant growth.  This suggests that 
symptoms alone cannot define UTI and that further investigation is warranted to 
determine the source of decompensation in LTC residents.  Our study also saw that there 
is much to be improved in the way antibiotics are prescribed in LTC; many physicians 
were inappropriate in their treatment decision and in certain cases, chose not to treat at 
all.  Further investigation is also needed to develop a well-defined, reliable diagnostic 
criterion for UTI in LTC that is mindful of the high prevalence of ASB.  
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Appendix  
Appendix 1: Study Information Sheet  
 
Letter of Information Regarding Research Study 
 
TITLE: Pilot Prospective Observational Study of Diagnosis of Urinary Tract Infection (UTI) in 
Long Term Care (LTC)    
 
INVESTIGATOR(S): Peter Daley MD, Aaron McKim MD, Natalie Bridger MD, Glenda 
Compton RN, Judy O’Keefe RN, Susan Wakeham BSc   
 
You have been invited to take part in a research study.  Taking part in this study is 
voluntary.  It is up to you to decide whether to be in the study or not.  You can decide not 
to take part in the study.  If you chose not to take part, please say “No” to the research 
staff.  If you decide to take part, you are free to leave at any time.  
 
The study has been reviewed by the Health Research Ethics Authority and granted 
approval.     
 
Before you decide, you need to understand what the study is for, what risks you might 
take and what benefits you might receive.  This information sheet explains the study.  A 
researcher will discuss the study with you and provide a copy of this information letter to 
you before you decide to participate.  Your verbal consent will be requested before any 
information is collected.    
 
Please read this carefully. Take as much time as you like. If you like, take it home to think about for 
a while. Mark anything you do not understand, or want explained better. After you have read it, 
please ask questions about anything that is not clear. 
 
The researchers will: 
• discuss the study with you 
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• answer your questions 
• keep confidential any information which could identify you personally 
• be available during the study to deal with problems and answer questions 
 
1. Introduction/Background: 
The diagnosis of urinary tract infection (UTI) in long term care facilities (LTC) is 
difficult, since many residents have positive urine culture at all times.  The 
researchers are looking at why nursing staff decide to collect urine for culture from 
residents.  Also, are the same symptoms present during antibiotic treatment for UTI?   
 
2.    Purpose of study: 
Since antibiotic treatment is often given inappropriately, the researchers are 
interested in improving the diagnosis and treatment of UTI in LTC.   
 
3.    Description of the study procedures: 
Nursing staff familiar with a resident will be approached by a research team member 
if a urine sample has been collected for culture.  The research team member will 
inquire about the resident’s baseline level of function and what change in functional 
status has been observed.  The nursing staff is requested to provide verbal answers to 
questions to complete the case report form.  The research team member will consider 
laboratory results and antibiotic treatment decisions.  The same assessment will be 
performed after 2 days and again after 7 days from the day of urine collection.  The 
study will not influence decision making by nursing staff.    
    
4.    Length of time: 
 
The study will collect information from 100 LTC residents with suspected UTI.  This 
is expected to take 1-2 months during the summer of 2013.  Each interview of 
nursing staff to collect the relevant information will take less than ten minutes.      
 
5.    Possible risks and discomforts: 
 
The study is considering decision making by nursing staff.  Staff members will not be 
identified by name and no feedback about individual decision making will be 
provided to nursing staff.   Discomfort to nursing staff will include time required to 
answer questions about resident status information.        
 
6.    Benefits: 
 
It is not known whether this study will benefit residents.  If we find useful information about 
diagnosis of UTI in LTC, it could lead to change in policy regarding collection and 
interpretation of urine culture information.  The study will not directly benefit nursing staff. 
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7.    Liability statement: 
 
This information sheet is designed to explain the study to nursing staff and ensure 
that nursing staff understand fully.  If you choose to participate, you do not give up 
your legal rights.  Researchers or agencies involved in this research study still have 
their legal and professional responsibilities. 
 
 
 
8.    What about my privacy and confidentiality?  
 
Protecting your privacy is an important part of this study.  Every effort to protect your 
privacy will be made. However it cannot be guaranteed.  For example we may be required by 
law to allow access to research records.   
 
        When you provide verbal consent for participation you give us permission to:  
• Collect resident status information from you, without identifying you by name 
• Share information with the people conducting the study 
• Share information with the people responsible for protecting your safety        
 
Access to records 
The members of the research team will see study records that identify the facility by 
name. 
Other people may need to look at study records that identify the facility by name. 
This might include the research ethics board. You may ask to see the list of these 
people. They can look at study records only when supervised by a member of the 
research team.  
 
Use of your study information 
The research team will collect and use only the information they need for this 
research study.  This information will include:  
• Reasons that nursing staff decide that a resident may have UTI 
• Resident demographic and clinical information but not resident identification, 
including activities of daily living, mental status, vital signs and symptoms 
• Urine culture results 
• Antibiotic treatment decisions 
• Resident clinical status after urine culture collection, at day 2 and day 7 
 
Your facility name and contact information will be kept secure by the research team 
in Newfoundland and Labrador.  It will not be shared with others without your 
permission. Your name will not appear in any report or article published as a result 
of this study.  Information collected for this study will kept for five years. 
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If you decide to withdraw from the study, the information collected up to that time 
will continue to be used by the research team.  It may not be removed.  This 
information will only be used for the purposes of this study.  Information collected 
and used by the research team will be stored at the office of Peter Daley at the Health 
Sciences Center.  Dr. Daley is the person responsible for keeping it secure.  
 
Your access to records 
You may ask the researcher to see the information that has been collected about your 
facility.   
 
 
 
 
9.    Questions or problems: 
 
If you have any questions about taking part in this study, you can meet with the investigator 
who is in charge of the study at this institution.  That person is:  
Peter Daley MD, principal investigator.   
Room 1J421, 300 Prince Phillip Dr. A1B 3V6  
709-777-2089 or 709-777-7801 (Meaghan Lethbridge) 
 
Or you can talk to someone who is not involved with the study at all, but can advise you on 
your rights as a participant in a research study.  This person can be reached through: 
Ethics Office 
Health Research Ethics Authority 
709-777-6974 or by email at info@hrea.ca 
 
10.   Declaration of financial interest, if applicable   
 
There is no financial support or external budget to conduct the study.  
  
Copies will be made available to each staff member at a participating facility, and posted at 
each nursing unit, in order to inform staff about the study details.   
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Appendix 2: Health Research Ethics Authority approval   
  
Ethics Office  
Suite 200, Eastern Trust Building  
95 Bonaventure 
Avenue St. 
John’s, NL    
A1B 2X5  
  
June 21, 2013  
  
Dr. Peter Daley  
Health Science Centre  
300 Prince Philip Drive  
St. John’s, NL  
  
Dear Dr. Daley  
  
Reference #13.127  
  
RE:  Pilot Prospective, Observational Study of Diagnosis of Urinary Tract Infection (UTI) in 
Long  
Term Care (LTC)    
  
This will acknowledge receipt of your correspondence.  
  
This correspondence has been reviewed by the Chair under the direction of the Board.  Full board 
approval of this research study is granted for one year effective June 13, 2013.  
  
This is to confirm that the Health Research Ethics Board reviewed and approved or acknowledged 
the following documents (as indicated):  
• Application, approved  
• Letter of information, dated June 19, 2013 version 2, approved  
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• Letter to Medical Records, acknowledged  
  
MARK THE DATE  
This approval will lapse on June 12, 2014.  It is your responsibility to ensure that the Ethics 
Renewal form is forwarded to the HREB office prior to the renewal date.  The information 
provided in this form must be current to the time of submission and submitted to HREB  not less 
than 30 nor more than 45 days of the anniversary of your approval date.  The Ethics Renewal 
form can be downloaded from the HREB website http://www.hrea.ca.  
  
The Health Research Ethics Board advises THAT IF YOU DO NOT return the completed Ethics 
Renewal form prior to date of renewal:  
  
▪ Your ethics approval will lapse  
▪ You will be required to stop research activity immediately  
▪ You may not be permitted to restart the study until you reapply for and receive approval 
to undertake the study again  
  
  
Lapse in ethics approval may result in interruption or termination of funding  
  
It is your responsibility to seek the necessary approval from the Regional Health Authority 
or other organization  as appropriate.  
  
Modifications of the protocol/consent are not permitted without prior approval from the 
Health Research Ethics Board.  Implementing changes in the protocol/consent without 
HREB approval may result in the approval of your research study being revoked, 
necessitating cessation of all related research activity.  Request for modification to the 
protocol/consent must be outlined on an amendment form (available on the HREB website) 
and submitted to the HREB for review.  
  
This research ethics board (the HREB) has reviewed and approved the research protocol 
and documentation as noted above for the study which is to be conducted by you as the 
qualified investigator named above at the specified site.  This approval and the views of this 
Research Ethics Board have been documented in writing.  In addition, please be advised 
that the Health Research  
Ethics Board currently operates according to Tri-Council Policy Statement: Ethical Conduct 
for Research Involving Humans; ICH Guidance E6: Good Clinical Practice and applicable 
laws and regulations.  The membership of this research ethics board is constituted in 
compliance with the membership requirements for research ethics boards as defined by 
Health Canada Food and Drug Regulations Division 5; Part C.  
  
Notwithstanding the approval of the HREB, the primary responsibility for the ethical conduct of 
the investigation remains with you.  
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We wish you every success with your study.   
  
Sincerely,  
  
  
  
Dr. Fern Brunger  
Chair, Non-Clinical Trials  
Health Research Ethics Board  
        
  
  
C C  VP Research c/o Office of Research, MUN  
  VP Research c/o Patient Research Centre, Eastern Health  
HREB meeting date:  June 27, 2013   
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Appendix 3: Case Report Form 
 
UTI in LTC Case Report Form 
Researcher to complete, based on interview of nursing staff 
SECTION 1:  Demographics 
Study Number (1-100) Date of Birth LTC Home: Gender 
 
 
 
 
______/_________/_______ 
    Day      Month           Year 
 
☐  Hoyles Escasoni (1)             ☐  Agnes Pratt  (5) 
☐  Masonic Park (2)                  ☐  St. Lukes’s  (6)                                      
☐  GlenBrook Lodge  (3)             
☐ St. Patrick’s (4) 
 
 
 
☐  Female (0)   ☐  Male (1) 
 
SECTION 2:  Exclusion Criteria (Please tick the following that apply):  (If excluded from study, no further data collected) 
 
☐  Not anticipated to remain in the Nursing home for long-term care (1)     ☐  Undergoing dialysis  (6) 
 
☐  Terminal (anticipated life expectancy <4 weeks) (2)       ☐  Undergoing chronic suppressive antibiotic therapy for recurrent UTI (7)  
 
☐  Younger than 65 years (3)                            ☐  Completed a course of antibiotics within the last 7 days for any reason  (8) 
  
☐  Indwelling catheter  (4) 
 
☐  Resided in the nursing home for less than 4 weeks (5)  
 
SECTION 3:  Inclusion Criteria 
Date of Urine Submission Reason For Suspected UTI (Please tick all of the following that apply): 
 
______/_________/_______ 
      Day      Month        Year 
 
 
☐  Change in mental status (1)          ☐  Flank pain  (7)    ☐  Other infection (13) 
 
☐  Change in behavior (2)   ☐  Other workup (8)     ☐  Change in functional status (14) 
 
 
Date of Interview of Nursing Staff 
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______/_________/_______ 
      Day      Month        Year 
 
Was the nurse who suspected UTI 
(collected urine) interviewed? 
 
☐  Yes (1)   
☐  No, someone else  (0) 
☐  Change in character of urine (3)   ☐  Patient or family request (9)    ☐  Previous UTI  (15) 
 
☐  Fever or chills (4)                  ☐  Abnormal laboratory test result (10) ☐  Malaise (16) 
 
☐  Change in gait or fall (5)   ☐  Syncope (11)     ☐  Dehydration  (17) 
 
☐  Change in voiding pattern (6)       ☐  Dysuria (12)     
 
☐  Other(18):  Describe:  ____________________________________________________________________________  
        
 
SECTION 4:  Baseline Assessment 
Comorbidities (yes/no): 
 
________   Dementia (1)    ________   Depression (4)    ________   Cancer  (7) 
 
________   Stroke  (2)     ________   Kidney Disease (5)   ________   Chronic Obstructive Pulmonary Disease  (8) 
 
________   Liver Disease  (3)   ________   Diabetes  (6)    ________   Congestive Heart Failure  (9)   
 
ADL: Independent (0 Points) Light Assist (1 Point) Moderate Assist (2 Points) Heavy Assist (3 Points) Total Dependence (4 Points) 
Bed Mobility  
    
Transfer 
 
 
 
 
   
Locomotion within  
facility 
     
Dressing 
     
Toilet Use 
     
Personal Hygiene 
     
Eating 
     
Total Score: 
 
__________/28 
 
 
55 
 
 
Mental Status (present/absent in the last 7 days): Last recorded Vital Signs     DD/MM/YYYY ___/___/_____ 
 
________   Episodes of Disorganized Speech       ________   Unresponsive 
 
 
________   Periods of Altered Perception              ________   Periods of Lethargy 
 
 
Total Score:  __________/ 4 
 
 
Temperature:  _____________°C       Heart Rate: ___________ BPM 
 
 
Blood Pressure:  __________/___________      O2 Saturation: ___________% 
 
 
SECTION 5:  New Symptoms as Perceived by Patient or Attendant 
Constitutional 
 
☐  Fever (1)       ☐  Cough  (4)   ☐  Shortness of Breath (7)  
 
☐  Behavior Change  (2)      ☐  Diarrhea  (5)   ☐  Weakness or Fatigue (8) 
 
☐  Mental Status Change  (3)                                                     ☐  Abdominal Pain (6)  ☐  Functional Decline (New ADL Score:  ______/28) (9)  
           ☐ Acute Onset         ☐ Fluctuating Course 
           ☐ Inattention            ☐ Disorganized Thinking  or Decreased Consciousness   
Genitourinary Vital Signs (if recorded as part of routine care)      DD/MM/YYYY ___/___/_____ 
☐  Dysuria (1)      ☐  Change in Frequency of Urination (3) 
 
☐  Change in Character of Urine (2)   ☐  Flank Pain (4) 
Temperature:  _____________°C        Heart Rate: ___________ BPM 
 
Blood Pressure:  __________/___________       O2 Saturation: ___________% 
 
SECTION 6:  Lab Data if Collected 
Method of Collection  Dipstick Results  Urinalysis Results  
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☐  Clean Catch (1)   ☐  In/Out Catheter (2) 
 
 
☐  Other (3): _____________________ 
 
Glucose   __________ Protein  __________    Blood__________ 
 
Bilirubin    __________ Casts  __________ 
 
Ketones   __________ Nitrite  __________ 
 
PH   __________ Leukocyte __________ 
 
Specific Gravity  __________ Urobilinogen __________ 
 
RBC         __________/HPF 
 
 
WBC           __________/HPF 
   
 
Epithelials     __________/HPF 
 
 
Other        __________/HPF 
WBC Count and Differential  Culture Results 
 
 
WBC____________ X 109/L 
 
Bands __________x 109/L   _______% 
 
☐  Contamination (1) 
☐  No Growth (0)  
☐  Growth (2):  Count   ____________ X 106 CFU/L   
 Identification:      ________________________________________________________ 
 
Second Urine Culture Submission                                                                                            Collection Date       ___/___/____ 
                                                                                                                                                                                                                                                 DD/MM/YYYY 
Method of Collection  Dipstick Results  Urinalysis Results  
 
 
☐  Clean Catch (1)   ☐  In/Out Catheter (2) 
 
 
☐  Other (3): _____________________ 
 
Glucose   __________ Protein  __________    Blood__________ 
 
Bilirubin    __________ Casts  __________ 
 
Ketones   __________ Nitrite  __________ 
 
PH   __________ Leukocyte __________ 
 
Specific Gravity  __________ Urobilinogen __________ 
 
RBC         __________/HPF 
 
 
WBC           __________/HPF 
   
 
Epithelials     __________/HPF 
 
 
Other        __________/HPF 
Culture Results 
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☐  Contamination(1) 
☐  No Growth (0)  
☐  Growth(2):  Count   ____________ X 106 CFU/L   
 Identification:      ________________________________________________________ 
 
 
Third Urine Culture Submission                                                                                               Collection Date       ___/___/____ 
                                                                                                                                                                                                                                                 DD/MM/YYYY 
Method of Collection  Dipstick Results  Urinalysis Results  
 
 
☐  Clean Catch (1)   ☐  In/Out Catheter (2) 
 
 
☐  Other (3): _____________________ 
 
Glucose   __________ Protein  __________    Blood__________ 
 
Bilirubin    __________ Casts  __________ 
 
Ketones   __________ Nitrite  __________ 
 
PH   __________ Leukocyte __________ 
 
Specific Gravity  __________ Urobilinogen __________ 
 
RBC         __________/HPF 
 
 
WBC           __________/HPF 
   
 
Epithelials     __________/HPF 
 
 
Other        __________/HPF 
Culture Results 
 
☐  Contamination (1) 
☐  No Growth (0)  
☐  Growth (2):  Count   ____________ X 106 CFU/L   
 Identification:      ________________________________________________________ 
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SECTION 7:  Treatment Decision 
Drug Dose Route and Frequency Duration 
   
___/___/____           ___/___/____ 
DD/MM/YYYY until DD/MM/YYYY 
 
 
 
 
 
 
 
 
 
SECTION 8:  McGeer Criteria (Circle answer): 
Fever: 
 
Single oral temperature  >37.8°C YES/NO/NOT COLLECTED (1/0/2) 
 
Repeated oral temperatures >37.2°C or rectal temperatures >37.5°C   
 
   YES/NO/NOT COLLECTED (1/0/2) 
Leukocytosis: 
 
Neutrophilia (>14,000 leukocytes/mm3 ) YES/NO/NOT COLLECTED (1/0//2) 
 
Left shift (>6% bands or ≥1,500 bands/mm3 )   YES/NO/NOT COLLECTED (1/0/2) 
Acute Change in Mental Status: 
 
Acute onset  YES/NO (1/0)  
Fluctuating Course YES/NO (1/0) 
Inattention YES/NO (1/0) 
Either disorganized thinking or altered level of consciousness YES/NO (1/0) 
Acute Functional Decline: 
 
New 3-point increase in total activities of daily living (ADL) Score      YES/NO (1/0) 
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For Residents without an Indwelling Catheter (Both Criteria 1 and 2 must be present): 
 
1. At least one of the following sign or symptom subcriteria: 
 
a) Acute dysuria or acute pain, swelling, or tenderness of the testes, epididymis, or prostate  YES/NO (1/0) 
 
b) Fever or leukocytosis and at least one of the following localizing urinary tract subcriteria 
 
i. Acute costovertebral angle pain or tenderness  YES/NO (1/0) 
ii. Suprapubic pain     YES/NO (1/0) 
iii. Gross hematuria     YES/NO (1/0) 
iv. New or marked increase in incontinence  YES/NO (1/0) 
v. New or marked increase in urgency   YES/NO (1/0) 
vi. New or marked increase in frequency  YES/NO (1/0) 
 
c) In the absence of fever or leukocytosis, then two or more of the following localizing urinary tract subcriteria 
 
i. Suprapubic pain    YES/NO (1/0) 
ii. Gross hematuria    YES/NO (1/0) 
iii. New or marked increase in incontinence YES/NO (1/0) 
iv. New or marked increase in urgency  YES/NO (1/0) 
v. New or marked increase in frequency YES/NO (1/0) 
 
2. One of the following microbiologic subcriteria 
 
a) At least 105 cfu/mL of no more than 2 species of microorganisms in a voided urine sample  YES/NO (1/0) 
 
b) At least 102 cfu/mL of any number of organisms in a specimen collected by in-and-out catheter YES/NO (1/0) 
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SECTION 9:  Reassessment of Symptoms 48 Hours after UTI Suspected   performed DD/MM/YYYY  ___/____/_____ 
Constitutional 
 
☐  Fever (1)       ☐  Cough  (4)   ☐  Shortness of Breath (7)  
 
☐  Behavior Change  (2)      ☐  Diarrhea  (5)   ☐  Weakness or Fatigue (8) 
 
☐  Mental Status Change  (3)                                                     ☐  Abdominal Pain (6)  ☐  Functional Decline (9)  
           ☐ Acute Onset         ☐ Fluctuating Course 
           ☐ Inattention            ☐ Disorganized Thinking  or Decreased Consciousness   
Genitourinary 
 
☐  Dysuria (1)        ☐  Change in Frequency of Urination (2)  ☐  Change in Character of Urine (3)          ☐  Flank Pain (4) 
 
ADL: Independent (0 Points) Light Assist (1 Point) Moderate Assist (2 Points) Heavy Assist (3 Points) Total Dependence (4 Points) 
Bed Mobility  
    
Transfer 
 
 
 
 
   
Locomotion within  
facility 
     
Dressing 
     
Toilet Use 
     
Personal Hygiene 
     
Eating 
     
Total Score: 
 
__________/  28 
 
Mental Status (present/absent): Vital Signs (if recorded as part of routine care)      DD/MM/YYYY __/___/_____ 
 
________   Episodes of Disorganized Speech       ________   Unresponsive 
 
 
Temperature:  _____________°C       Heart Rate: ___________ BPM 
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SECTION 10:  Reassessment of Symptoms 5-7 days after UTI Suspected    performed DD/MM/YYYY  ___/____/_____ 
Constitutional 
 
☐  Fever (1)       ☐  Cough  (4)   ☐  Shortness of Breath (7)  
 
☐  Behavior Change  (2)      ☐  Diarrhea  (5)   ☐  Weakness or Fatigue (8) 
 
☐  Mental Status Change  (3)                                                     ☐  Abdominal Pain (6)  ☐  Functional Decline (9)  
           ☐ Acute Onset         ☐ Fluctuating Course 
           ☐ Inattention            ☐ Disorganized Thinking  or Decreased Consciousness   
Genitourinary 
 
☐  Dysuria (1)        ☐  Change in Frequency of Urination (2)  ☐  Change in Character of Urine (3)          ☐  Flank Pain (4) 
 
ADL: Independent (0 Points) Light Assist (1 Point) Moderate Assist (2 Points) Heavy Assist (3 Points) Total Dependence (4 Points) 
Bed Mobility  
    
Transfer 
 
 
 
 
   
Locomotion within  
facility 
     
Dressing 
     
Toilet Use 
     
Personal Hygiene 
     
Eating 
     
 
________   Periods of Altered Perception              ________   Periods of Lethargy 
 
Total Score:  __________/ 4 
 
 
 
Blood Pressure:  __________/___________      O2 Saturation: ___________% 
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Total Score: 
 
__________/  28 
 
Mental Status (present/absent): Vital Signs (if recorded as part of routine care)      DD/MM/YYYY __/___/_____ 
 
________   Episodes of Disorganized Speech       ________   Unresponsive 
 
 
________   Periods of Altered Perception              ________   Periods of Lethargy 
 
Total Score:  __________/ 4 
 
 
Temperature:  _____________°C       Heart Rate: ___________ BPM 
 
 
Blood Pressure:  __________/___________      O2 Saturation: ___________% 
 
 
 
 
 
 
